$ACMR

Cheav Sotheara sold $244K of ACMR

Cheav Sotheara (See remarks) sold 2,839 shares of ACM Research, Inc. (ACMR) at $85.77 ($0.24M total) on 2026-06-04 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Cheav Sotheara
Published Jun 6, 2026, 1:00 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 6, 2026, 1:03 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$ACMR
Neutral
medium confidence
Mentioned
$ACMR
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ACMRNeutralLow
01

Why it matters

The disclosure may slightly influence short-term sentiment, but it is not a fundamental catalyst given the stated 10b5-1 pre-arranged plan.

02

Market read

Traders may note the insider sale for sentiment/positioning, but the 10b5-1 designation suggests limited informational content.

03

What to watch

The article provides only one transaction size and does not indicate whether there were offsetting buys, broader insider activity trends, or changes in company guidance.

Relevance 6/10Novelty 3/10Timing: Filed 2026-06-05 after the sale executed 2026-06-04

Background

This is an SEC Form 4 insider transaction (officer/direct ownership) for ACM Research, Inc.

Company-level read

Ticker impact

$ACMRNeutralMedium confidence
Context

ACMR officer Cheav Sotheara sold 2,839 shares in an open-market transaction disclosed via SEC Form 4 on 2026-06-04.

Expected impact

Likely minimal near-term impact; any effect is more sentiment/positioning than fundamentals.

Evidence & confidence

The filing is an ownership-change disclosure with a stated Rule 10b5-1 pre-arranged plan, reducing the likelihood it reflects new, nonpublic information.

Market effects

No clear sector read-through from a single 10b5-1 insider sale.

None indicated.

None indicated.

Counterpoint

Because the sale is under a pre-arranged 10b5-1 plan, it may reflect routine liquidity rather than a view on ACMR fundamentals.

Key entities

  • ACM Research, Inc.

    Public company whose officer disclosed an open-market sale of common shares via SEC Form 4.

  • Cheav Sotheara

    Officer who executed and reported the sale under a Rule 10b5-1 plan.

Related articles

$ACMRMed

ACM Research, Inc. Q2 2026 Earnings Call Summary

ACM Research (ACM) reported Q2 2026 revenue up 36% YoY, driven by ECP and advanced packaging categories. The company said it received panel-level horizontal plating orders from two customers and expects full-year 2026 revenue guidance of $1.125B to $1.175B. It noted cleaning revenue fell 14% and net cash exceeds $1B.